Meghan J Chenoweth

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Molecularly Imprinted

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Meghan J Chenoweth, Yong Jae Kim, Nikki L Nollen, Larry W Hawk, Martin C Mahoney, Caryn Lerman, Joanne Knight, Rachel Fynvola Tyndale
Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome-Wide Investigation of Abnormal Dreams on Varenicline. Clinical pharmacology and therapeutics 115 (6) (2024)
Alec W R Langlois, Meghan J Chenoweth, David Twesigomwe, Giada Scantamburlo, Michelle Whirl-Carrillo, Katrin Sangkuhl, Teri E Klein, Charity Nofziger, Rachel Fynvola Tyndale, Andrea Gaedigk
PharmVar GeneFocus: CYP2A6. Clinical pharmacology and therapeutics (2024)
Meghan J Chenoweth, Yong Jae Kim, Nikki L Nollen, Larry W Hawk, Martin C Mahoney, Caryn Lerman, Joanne Knight, Rachel Fynvola Tyndale
Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome-Wide Investigation of Abnormal Dreams on Varenicline. Clinical pharmacology and therapeutics (2024)
Intishar Kazi, Meghan J Chenoweth, Didier Jutras-Aswad, Keith Ahamad, M Eugenia Socias, Bernard Le Foll, Rachel Fynvola Tyndale
Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone. Clinical pharmacology and therapeutics (2023)